Latest Articles about CMN

Cantel's Mar Cor Buys Siemens Unit - Analyst Blog

Zacks Equity Research — Fri, 29 Mar 2013 02:25:55 Z

In an attempt to expand its North American footprint, Cantel Medical Corp. ( CMN ), a leading provider of infection prevention and control products, came up with its new acquisition deal.

Pre-Market Earnings Report for March 7, 2013 : CNQ, KR, BTE, SFD, NAV, JW/A, FGP, CIEN, EPL, PRIM, CMN, CLDX

NASDAQ.com News — Thu, 07 Mar 2013 02:00:03 Z

The following companies are expected to report earnings prior to market open on 03/07/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Canadian Natural

Luminex Beats EPS, Profits Up - Analyst Blog

Zacks Equity Research — Tue, 05 Feb 2013 20:10:01 Z

Luminex Corporation 's ( LMNX ) fourth-quarter 2012 adjusted earnings of 12 cents per share (up 9% year over year) beat the Zacks Consensus Estimate of 10 cents per share. Adjusted earnings

Libya First to Adopt Pronto-7 - Analyst Blog

Zacks Equity Research — Tue, 05 Feb 2013 01:00:01 Z

Masimo Corporation ( MASI ), a leader in non-invasive monitoring technology, recently revealed that Libya is the first nation to start utilizing the Masimo Pronto-7 to check prospective

Angio Closes Microsulis Deal - Analyst Blog

Zacks Equity Research — Mon, 04 Feb 2013 20:00:01 Z

AngioDynamics Inc. ( ANGO ), a provider of therapeutic and diagnostic devices for the treatment of peripheral vascular and other non-coronary diseases, completed its previously announced

Mixed Quarter for Haemonetics - Analyst Blog

Zacks Equity Research — Fri, 01 Feb 2013 19:50:01 Z

Haemonetics Corporation ( HAE ) reported net income of $9.9 million or earnings of 19 cents per share in the third quarter of fiscal 2013, down 46% and 47% year over year, respectively.

Encouraging Square Beat for Align - Analyst Blog

Zacks Equity Research — Fri, 01 Feb 2013 00:20:01 Z

Dental technology company Align Technology Inc . ( ALGN ) reported fourth quarter 2012 net earnings of $9.6 million (or 12 cents per share), considerably lower than the year-ago net

Varian Products Expand to Algeria - Analyst Blog

Zacks Equity Research — Thu, 31 Jan 2013 03:56:01 Z

As a part of its strategy to expand its reach in the global economy, Varian Medical Systems ( VAR ) announced the sale of its products to the Algerian government. The Varian Clinac iX

Intuitive Surgical to Outperform - Analyst Blog

Zacks Equity Research — Thu, 31 Jan 2013 00:18:53 Z

On Jan 29, 2013, we retained Intuitive Surgical ( ISRG ), the pioneer in minimally invasive robotic surgery, at Outperform following its strong results for the fourth quarter 2012. The

Hologic Exhibits at Arab Summit - Analyst Blog

Zacks Equity Research — Wed, 30 Jan 2013 04:39:01 Z

Hologic Inc. ( HOLX ), a leading provider of healthcare products for women, is currently showcasing some of its latest offerings at the 38th Arab Health Congress at the Dubai International

Cyberonics Approves Share Buyback - Analyst Blog

Zacks Equity Research — Wed, 30 Jan 2013 04:19:41 Z

In order to uphold investor confidence, neuromodulation company Cyberonics ( CYBX ) disclosed the approval of a new share repurchase program with authorization to repurchase one million

FDA Clears Varian's Vitesse - Analyst Blog

Zacks Equity Research — Wed, 30 Jan 2013 03:08:01 Z

Oncology and X-Ray products company, Varian Medical Systems ( VAR ) has won the U.S. Food and Drug Administration (FDA) 510(k) clearance for its Vitesse software. The tool is intended for

Reiterate Varian at Neutral - Analyst Blog

Zacks Equity Research — Wed, 30 Jan 2013 00:30:01 Z

On Jan 28, we retained Varian Medical Systems ( VAR ), an oncology and X-Ray products company, at Neutral after the company beat Zacks Consensus Estimates for revenues and earnings for the

Varian Receives FDA Clearance - Analyst Blog

Zacks Equity Research — Tue, 29 Jan 2013 00:18:55 Z

Oncology and X-Ray products company Varian Medical Systems ( VAR ) recently revealed that it has received FDA 510(k) clearance for its Edge radiosurgery offering. This is Varian's latest

FDA Clears Teleflex Needles - Analyst Blog

Zacks Equity Research — Mon, 28 Jan 2013 22:00:01 Z

Teleflex Incorporated ( TFX ) has obtained the approval of the U.S. Food and Drug Administration (FDA) for its Arrow UltraQuick peripheral nerve block (PNB) needles. The UltraQuik needles